Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-24-013091
Filing Date
2024-09-30
Accepted
2024-09-30 17:01:16
Documents
17
Period of Report
2024-05-31

Document Format Files

Seq Description Document Type Size
1 10-K/A cydy-20240531x10ka.htm   iXBRL 10-K/A 572621
2 EX-31.3 cydy-20240531xex31d3.htm EX-31.3 8461
3 EX-31.4 cydy-20240531xex31d4.htm EX-31.4 8470
4 GRAPHIC cydy-20240531x10ka004.jpg GRAPHIC 3735
  Complete submission text file 0001558370-24-013091.txt   899045

Data Files

Seq Description Document Type Size
5 EX-101.SCH cydy-20240531.xsd EX-101.SCH 6048
6 EX-101.DEF cydy-20240531_def.xml EX-101.DEF 46112
7 EX-101.LAB cydy-20240531_lab.xml EX-101.LAB 20905
8 EX-101.PRE cydy-20240531_pre.xml EX-101.PRE 17682
20 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20240531x10ka_htm.xml XML 11195
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-K/A | Act: 34 | File No.: 000-49908 | Film No.: 241340239
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)